In Brief
The role of presynaptic translation in long-term plasticity in the mature mammalian brain is controversial. Younts et al. find that presynaptic protein synthesis is essential for long-term plasticity of GABA release at rodent hippocampal inhibitory synapses.
INTRODUCTION
Long-term plasticity of neurotransmitter release critically regulates circuit function (Castillo, 2012) . Despite decades of research, the molecular basis of long-term changes in neurotransmitter release remains unsolved. While synthesis of new protein is required for stabilizing synapses during postsynaptically expressed forms of long-term plasticity (e.g., long-term potentiation [LTP] and long-term depression [LTD] ) (Buffington et al., 2014; Santini et al., 2014) , whether and how presynaptic protein synthesis is involved in long-term presynaptic plasticity in the mature mammalian brain is unclear. Resolving this issue is important given that LTP and LTD are linked to cognition, and dysregulated translation during long-term plasticity is associated with autism, fragile X syndrome, and Alzheimer disease (Buffington et al., 2014; Darnell and Klann, 2013; Santini et al., 2014) .
Presynaptic local protein synthesis, a process whereby mRNAs are translated in axons and terminals, can endow remote neuronal compartments with the flexibility to rapidly respond to local synaptic activity, independent of the soma (Alvarez et al., 2000) . Although ribosomes have routinely been documented in mammalian axonal growth cones during early embryonic development, as well as in regenerating, cultured, and peripheral sensory axons (for recent reviews, see Crispino et al., 2014; Gomes et al., 2014; Holt and Schuman, 2013; and Jung et al., 2014) , the prevailing view is that fully developed axons in the healthy mammalian brain are incapable of supporting protein synthesis. In non-mammalian preparations, where translation inhibitors can be injected into relatively large axons, a role for local protein synthesis during long-term plasticity has been established (Beaumont et al., 2001; Martin et al., 1997; Zhang and Poo, 2002) . Mammalian CNS axons are considerably smaller and, therefore, more difficult to experimentally manipulate. To date, a direct demonstration for a requirement for presynaptic protein synthesis during long-term plasticity in an intact mammalian CNS circuit is lacking. Moreover, there is very little evidence for the presence of ribosomes inside fully developed presynaptic axon terminals.
One of the most ubiquitously expressed forms of presynaptic plasticity in the mature CNS is mediated by retrograde endocannabinoid (eCB) signaling Kano et al., 2009) . eCBs are lipids mobilized by postsynaptic activity that travel backward across the synapse and bind presynaptic G i/o -coupled type 1 cannabinoid (CB 1 ) receptors to suppress neurotransmitter release. In the hippocampus, CB 1 receptors are highly expressed on GABAergic inhibitory interneuron axon terminals where they mediate both short-term and long-term plasticity. Short-term plasticity in the form of depolarizationinduced suppression of inhibition (DSI) typically lasts less than a minute and is likely due to a transient reduction of presynaptic calcium influx (Kano et al., 2009) . LTD of inhibition (iLTD) involves more sustained CB 1 activation (Chevaleyre and Castillo, 2003) , downregulation of PKA (Chevaleyre et al., 2007) , and a long-lasting reduction in GABA release. How eCBs control neurotransmitter release during long-term plasticity is incompletely understood. Although striatal eCB-LTD was reported to involve translation (Adermark et al., 2009; Yin et al., 2006 ; but see Jung et al., 2012) , the mechanism that triggers protein synthesis remains unknown. Furthermore, direct evidence that CB 1 activation leads to protein synthesis is unavailable.
To determine the role of presynaptic protein synthesis in iLTD, we performed long-term paired electrophysiological recordings on synaptically connected inhibitory interneurons and CA1 pyramidal cells in acute rodent hippocampal slices, where local microcircuits are intact. Using single-cell manipulations to block protein translation, we found that iLTD requires protein synthesis exclusively in presynaptic interneurons, most likely in axons. We also show that CB 1 activation increases protein synthesis in an mTOR-dependent manner and that iLTD involves cap-dependent translation. Moreover, using stochastic optical reconstruction microscopy (STORM), we provide evidence that eukaryotic ribosomes are localized inside CB 1 -expressing interneuron axon terminals. Our findings establish that presynaptic protein synthesis controls neurotransmitter release during long-term plasticity in the mature mammalian CNS.
RESULTS
Long-Term, but Not Short-Term, eCB-Mediated Plasticity Requires Protein Synthesis To assess if eCB-mediated iLTD involves protein synthesis, we first elicited heterosynaptic iLTD (Chevaleyre and Castillo, 2003) by theta-burst stimulation (TBS) of presynaptic inputs onto whole-cell voltage-clamped CA1 pyramidal cells in acute hippocampal slices. Compared with interleaved controls, acute bath application of either cycloheximide or anisomycin, two mechanistically distinct inhibitors of eukaryotic ribosome peptide elongation, impaired iLTD ( Figure 1A ). iLTD also can be triggered with postsynaptic activity such as multiple episodes of DSI (mDSI) (Younts et al., 2013) . Compared with controls, acute bath application, but not postsynaptic loading of cycloheximide (Yin et al., 2006) or anisomycin, blocked mDSI-iLTD ( Figure 1B ), suggesting that postsynaptic translation is dispensable for iLTD. Neither cycloheximide nor anisomycin affected the magnitude or duration of short-term plasticity triggered with DSI ( Figures  1C and 1D ), indicating that eCB release and CB 1 activation properly function when blocking protein synthesis. Using fluorescent non-canonical amino acid tagging (FUNCAT), a technique that permits visualization of newly synthesized proteins (Dieterich et al., 2010) , we confirmed that cycloheximide and anisomycin block translation in slices ( Figures 1E and 1F ). Taken together, these results show that protein translation is essential for longterm, but not short-term, inhibitory plasticity.
Protein Synthesis Is Required for the Induction, but Not Maintenance, of iLTD Bypassing eCB production and directly activating presynaptic CB 1 with the selective agonist WIN 55,212-2 (WIN) induces chemical iLTD (Chevaleyre and Castillo, 2003; Chevaleyre et al., 2007; Heifets et al., 2008) . Using extracellular field inhibitory postsynaptic potential (fIPSP) recordings from the cell body layer, we found that WIN paired with presynaptic activity triggered iLTD (Heifets et al., 2008) , which was expressed presynaptically as reflected by an increased paired-pulse ratio (i.e., reduced release probability, P r ) (Figure 2A ). Cycloheximide or anisomycin abolished iLTD and the associated change in P r ( Figure 2A ). To address whether translation is necessary for the induction or maintenance of iLTD, we acutely exposed slices to cycloheximide during or after CB 1 activation, and we found that protein synthesis was not required during the maintenance phase of iLTD ( Figure 2B ). Neither cycloheximide nor anisomycin affected basal inhibitory synapse strength ( Figure 2C ), indicating that protein synthesis is specifically required for long-term plasticity and that constitutive protein synthesis does not significantly alter GABA release. As expected, iLTD was prevented in slices exposed to the selective CB 1 inverse agonist/antagonist AM251 or SR 141716 ( Figure 2D ). We also examined the potential contribution of mRNA transcription to iLTD. iLTD remained intact when transcription was blocked with actinomycin-D (Figure S1A) , and actinomycin-D efficacy was confirmed using RT-PCR in slices ( Figure S1B ). Collectively, these findings indicate that protein synthesis, and not transcription, is required for the induction, but not maintenance, of iLTD.
CB 1 Activation Enhances Protein Translation
Given that CB 1 -mediated iLTD requires protein synthesis, we next tested whether CB 1 activation can promote translation. To increase the likelihood of detecting and quantifying potential CB 1 -mediated changes in protein synthesis, we used FUNCAT on cultured primary hippocampal neurons. Cultured neurons mainly express CB 1 in axons, but, unlike inhibitory interneurons in situ, they also express CB 1 in soma and dendrites (Irving et al., 2000; Twitchell et al., 1997) . Using MAP2 labeling to identify neurons, we found that WIN increased translation ( Figures  3A and 3B ). Co-application of WIN with AM251 abolished this effect ( Figures 3A and 3B ), indicating that CB 1 activation triggered translation. AM251 treatment alone did not significantly change the FUNCAT signal ( Figures 3A and 3B ), suggesting that basal CB 1 signaling is not coupled to protein synthesis. As expected, the WIN-induced increase in FUNCAT signal was greatly reduced by cycloheximide. Using the selective agonist DHPG, we confirmed that group I metabotropic glutamate receptors (mGluRs) engage protein synthesis (Huber et al., 2000) , indicating that the FUNCAT assay worked as intended. We also assessed protein translation in CB 1 -expressing axons and found that the FUNCAT signal in the presence of WIN was reduced by AM251 ( Figure 3C ). We conclude that neuronal CB 1 activation increases newly synthesized protein in neurons and axons.
Presynaptic CB 1 -Mediated iLTD Requires mTOR Signaling and Cap-Dependent Translation CB 1 can signal via the mammalian target of rapamycin (mTOR), p38 mitogen-activated protein kinase (MAPK), and/or MAPK/ extracellular signal-regulated kinase (ERK) pathways (Howlett et al., 2002) . Each of these pathways is known to regulate protein synthesis and play a role in postsynaptic forms of LTP and LTD (Buffington et al., 2014; Santini et al., 2014) . To test if CB 1 activation increases protein synthesis in an mTORdependent manner, we measured translation using FUNCAT in primary neurons, and we found that the mTOR-selective inhibitor torin-2 abolished the WIN-induced increase in translation ( Figures 4A and 4B ). Application of torin-2 alone had no significant effect on protein synthesis, suggesting that mTOR does not regulate constitutive protein synthesis ( Figures 4A  and 4B) . To examine whether mTOR plays a role in iLTD, we triggered iLTD in acute hippocampal slices. Compared with interleaved controls, torin-2 abolished synaptically ( Figure 4C ) and chemically induced iLTD ( Figure 4D ). Similar to protein synthesis (Figure 2B) , mTOR signaling was required during the induction, but not maintenance, of iLTD ( Figure 4D ). Notably, torin-2 alone did not affect basal inhibitory synapse strength (104.5% ± 2.2% of baseline; n = 4; p = 0.19735, paired t test; data not shown), suggesting that constitutive mTOR signaling does not modify basal GABA release. In addition, a different mTOR inhibitor, rapamycin, impaired iLTD ( Figure 4E ). We further examined the contribution of cap-dependent protein synthesis to iLTD. Chemical iLTD was blocked in slices exposed to 4EGI-1 (Figure 4E) , which disrupts the eukaryotic initiation factor 4F (eIF4F) complex at the level of eIF4E and eIF4G (Moerke et al., 2007) , as well as an integrated stress response inhibitor (ISRIB) ( Figure 4E ), which interferes with translation initiation by preventing the effects of phosphorylated eIF2a (Sekine et al., 2015) . Neither 4EGI-1 nor ISRIB alone had a significant effect on basal inhibitory fIPSP amplitude (4EGI-1: 106.4% ± 8.0% of baseline; n = 4; p = 0.48092, paired t test; ISRIB: 96.2% ± 2.6% of baseline; n = 7; p = 0.1974, paired t test; data not shown), further signifying that the effects of blocking translation were specific to long-term plasticity. We found a partial block of iLTD in slices treated with the p38 MAPK inhibitor SB 202190, whereas the ERK/MAPK inhibitor U-0126 had no effect ( Figure 4E ). Collectively, our results demonstrate that CB 1 activation drives protein synthesis in an mTOR-dependent manner and that cap-dependent translation is essential for iLTD.
Presynaptic, but Not Postsynaptic, Cap-Dependent Translation Is Critical for iLTD To directly test a role for presynaptic protein synthesis in iLTD at the single-cell level, we performed long-term paired electrophysiological recordings (up to 5 hr) between individual hippocampal interneurons and CA1 pyramidal cells. Paired recordings allow independent control over presynaptic and postsynaptic signaling, thereby providing a means to study neurotransmitter release from fully developed GABAergic synaptic terminals in an intact circuit. Protein synthesis was inhibited at the singlecell level using the small molecule, membrane-impermeable inhibitor M 7 GpppG (M7). M7 is an mRNA cap analog that competes with endogenous 7-methyl guanosine 5 0 -capped mRNAs for binding to eIF4E, one of several proteins comprising the eIF4F complex that regulates cap-dependent translation (Sonenberg and Hinnebusch, 2009) . Excess M7 has been used previously to disrupt translation-dependent forms of long-term plasticity (Beaumont et al., 2001; Huber et al., 2000) . To test whether iLTD requires presynaptic protein synthesis, M7 was loaded via the patch pipette directly into regular-spiking, DSIsensitive, and therefore CB 1 -expressing interneurons ( Figure 5A ). Remarkably, loading M7 presynaptically for >1 hr abolished iLTD (Figures 5B and 5C; Figure S2A ). We quantified GABA release during the baseline and after inducing iLTD in the following three ways: neurotransmitter release probability, P r , calculated as the number of synaptic release events, i.e., the inverse failure rate; synaptic efficacy, a measure of synaptic strength calculated by averaging all synaptic events including responses and failures; and synaptic potency, which is the average of only synaptic responses. P r , synaptic efficacy (Figures 5B and 5C) , and synaptic potency (baseline: 34.5 ± 12.8 pA versus after iLTD induction: 31.8 ± 11.0 pA; n = 6; p = 0.50625, paired t test; data not shown) remained stable (for up to 3 hr) after attempting to induce iLTD. These results reinforce the idea that disrupting constitutive presynaptic protein synthesis does not alter basal GABA release. M7 did not alter physiological parameters of interneurons, such as resting membrane potential (M7 loaded presynaptically: À62.9 ± 1.9 mV versus M7 not loaded presynaptically: À62.1 ± 1.8 mV; p = 0.73584, unpaired t test; n = 6 each) or input resistance (M7 loaded presynaptically: 275.4 ± 42.0 MU versus M7 not loaded presynaptically: 231.5 ± 51.5 MU; p = 0.52464, unpaired t test; n = 6 each). These results establish that presynaptic protein synthesis is critical for iLTD, and they further support a mechanism involving cap-dependent protein synthesis.
To examine the contribution of postsynaptic translation to presynaptic plasticity, M7 was loaded into CA1 pyramidal cells. As predicted, iLTD remained intact (Figures 5D-5F ; Figure S2A ). The magnitude of iLTD, reflected in the P r and synaptic efficacy measurements, was not significantly different from our previous experiments in which M7 was not present (Younts et al., 2013) . Consistent with multivesicular release from these terminals (Biró et al., 2006) , synaptic potency also was reduced (baseline: 34.5 ± 11.7 pA versus after iLTD induction: 16.8 ± 6.0 pA; n = 6; p = 0.03423, paired t test; data not shown). These experiments indicate that iLTD does not wash out of presynaptic or postsynaptic compartments, because iLTD was induced in recordings in which the baseline exceeded 1 hr. Notably, iLTD was still CB 1 dependent when postsynaptic translation was blocked with M7 ( Figure S2B ), signifying that blocking postsynaptic protein synthesis does not alter eCB production or CB 1 signaling required for inducing iLTD. To validate that M7 worked as intended, we assessed the well-characterized, protein synthesisdependent mGluR-LTD at excitatory Schaffer collateral-to-CA1 pyramidal cell synapses (Huber et al., 2000) , and we found that mGluR-LTD, triggered chemically with DHPG, was not observed when M7 was loaded postsynaptically for $30 min ( Figure S2C) . 
CB 1 Activation Increases Protein Synthesis in Neurons
(A) Representative fluorescence images show FUNCAT signal acquired from primary hippocampal neurons (confirmed with MAP2 immunostaining, which exclusively labels neurons) exposed for 25 min to vehicle control (DMSO), the CB 1 agonist WIN (5 mM), WIN and AM251 (both at 5 mM), AM251 alone (5 mM), WIN and cyclo (5 mM and 80 mM, respectively), or DHPG (50 mM, 10 min). (B) Summary data. FUNCAT fluorescence intensity, in arbitrary units, was normalized to control. Control (eight wells, three replicates): 1.00 ± 0.03 versus WIN (seven wells, three replicates): 1.28 ± 0.04 versus WIN + AM251 (nine wells, two replicates): 0.99 ± 0.03 versus AM251 alone (three wells, two replicates): 0.90 ± 0.04 versus WIN + cyclo (four wells, two replicates): 0.63 ± 0.02 versus DHPG (nine wells, three replicates): 1.20 ± 0.04; F[5,401] = 28.09; **p < 0.01 and ****p < 0.0001, one-way ANOVA. ROIs were generated from neuronal somata and neurites using MAP2. Number in parentheses refers to the number of images analyzed (i.e., two to eight neurons/image and approxiamtely five images/well). (C) Top panels: representative fluorescence images of FUNCAT signal acquired from putative axons under CB 1 -positive puncta exposed to WIN (5 mM) and WIN + AM251 (both at 5 mM). Bottom left: wide-field image of a neuron immunostained with CB 1 and MAP2 is shown. Arrowheads indicate putative axons containing CB 1 but lacking MAP2 staining. Right: summary data of FUNCAT fluorescence intensity, in arbitrary units, was normalized to WIN + AM251. WIN (seven wells, two replicates): 1.42 ± 0.09 versus WIN + AM251 (six wells, two replicates): 1.00 ± 0.02; U = 202, ***p < 0.001, Mann-Whitney. Number in parentheses refers to the number of images analyzed (i.e., one to two neurons/image and approximately five images/well). Data represent mean ± SEM.
These results demonstrate that postsynaptic translation is dispensable for iLTD.
Somatic Protein Synthesis in Presynaptic Interneurons
Is Dispensable for iLTD Given that CB 1 is predominantly localized to hippocampal interneuron axons and terminals in situ (Dudok et al., 2015; Katona et al., 1999) , that iLTD is expressed presynaptically as reduced GABA release , and that loading M7 into interneurons blocked iLTD (Figures 5A-5C ; Figure S2A ), we hypothesized that translation is required locally in axons and/or terminals that are remote from the interneuron cell body. Consistent with this hypothesis, we found a significant positive correlation between the amount of time M7 was loaded presynaptically and the likelihood of blocking iLTD ( Figure S3A ), suggesting that M7 must diffuse into remote axonal compartments to exert its blocking effect. For the experiments in which M7 was omitted from the presynaptic interneuron, the magnitude of iLTD remained stable and no correlation was observed ( Figure S3A ). To determine if M7 can diffuse into remote axons at times matching iLTD block, we used two-photon fluorescence microscopy to track the diffusion of two fluorescent molecules, Alexa Fluor-594 and Lucifer yellow, which are similar in size to M7 (i.e., M7 proxies). We readily detected M7 proxies in putative axons ( Figures S3B and S3C) .
To test the hypothesis that somatic translation in interneurons is dispensable for iLTD, we performed paired recordings and loaded the type 1 ribosome-inactivating toxin, gelonin, which irreversibly interferes with protein elongation, into regularspiking, DSI-sensitive interneurons. Given its relatively large size ($30 kDa), we reasoned that gelonin introduced via the patch pipette would be relatively restricted to the soma and proximal neurites and, therefore, less effective at blocking were replotted for comparison. iLTD was blocked in slices acutely exposed (washed out after induction) to the mTOR inhibitor rapamycin (100 nM) (control: 74.2% ± 3.4% versus rapamycin: 91.3 ± 2.3; p = 0.00054) and the cap-dependent translation inhibitor 4EGI-1 (1 mM) (control: 80.5% ± 2.6% versus 4EGI-1: 100.3% ± 3.4%; p = 0.00169). ISRIB (1 mM), a different cap translation inhibitor, blocked iLTD in slices pre-incubated (>1 hr) and continuously perfused (control: 80.1% ± 2.4% versus ISRIB: 95.8% ± 4.4%; p = 0.00408). iLTD was partially blocked in slices acutely exposed (washed out after induction) to the p38 MAPK inhibitor SB 202190 (10 mM) (control: 66.7% ± 3.9% versus SB 202190: 79% ± 1.2%; p = 0.01661), but not the MAPK/ERK inhibitor U-0126 (10 mM) (control: 69.2% ± 5.3% versus U-0126: 79.8% ± 6.1%; p = 0.13075). The inactive form of U-0126, U-0124, was used as control. Unpaired t tests. Data are shown as mean ± SEM. translation in distal axon terminals. We could only detect gelonin (3-30 mM, labeled with Alexa Fluor-488) in somata and proximal dendrites, but not in putative axons ( Figures S3B and  S3C) . Functionally, gelonin (3 mM) loaded presynaptically for 105.3 ± 4.9 min failed to block iLTD ( Figures 6A and 6B ). To assess if gelonin blocked somatic translation, we loaded gelonin (3 mM) for $30 min into one of two neighboring CA1 interneurons in slices and performed FUNCAT ( Figures 6C and 6D ). Gelonin substantially reduced somatic translation in these interneurons ( Figures 6C and 6D) . As a functional positive control in interleaved experiments, we found that gelonin (3 mM) loaded postsynaptically for $30 min readily blocked mGluR-LTD at excitatory synapses onto CA1 pyramidal cells ( Figure 6E ). Finally, we examined the possibility that a somatically synthesized protein might traffic along microtubules into axonal compartments during iLTD. Slices were pre-incubated and continuously perfused with the microtubule-depolymerizing agent colchicine (for up to 5 hr) or nocodazole (for up to 8 hr). These reagents had no effect on iLTD ( Figure 6F ) or intrinsic membrane properties ( Figure S4A ), despite nocodazole disrupting neuronal microtubule integrity in slices as measured with second harmonic generation microscopy ( Figures S4B and  S4C ). These observations suggest that microtubule-based trafficking mechanisms do not participate in iLTD. Taken together, these results indicate that somatic translation and transport are not required for iLTD, strongly suggesting that iLTD involves presynaptic protein synthesis in axons.
Anatomical Evidence for Ribosomes in Mature Mammalian Axon Terminals
If iLTD involves presynaptic protein synthesis, then ribosomes should be present in CB 1 -expressing interneuron axons and 24.3 ± 8.7 pA versus after iLTD induction: 9.0 ± 4.5 pA; p = 0.01699, paired t test. The baseline P r and synaptic efficacy were not statistically different between gelonin loaded presynaptically and M7 loaded postsynaptically, which served as control (p = 0.64124 and p = 0.98827, respectively, unpaired t tests) (cf. Figure 5F ). terminals. To visualize ribosomes specifically within this interneuron type, we co-immunostained mouse and rat hippocampal slices using antibodies specific for CB 1 and ribosomes. We and others have previously validated the CB 1 antibody (Dudok et al., 2015; Fukudome et al., 2004) . The Y10b antibody is also well characterized and validated, recognizing 5.8S non-coding rRNA in the 60S subunit. Consistent with previous reports (Dudok et al., 2015; Katona et al., 1999) , confocal imaging revealed a characteristically dense network of CB 1 -expressing basketlike axons and preterminal axon segments encircling CB 1 -immunonegative CA1 pyramidal cell bodies ( Figure 7A ; Figure S5A ). As expected, there was high ribosome density expressed in the perinuclear cytoplasm of CA1 pyramidal cell bodies (Figure 7A ; Figure S5A ). With the exception of nucleoli (not shown), where 5.8S rRNA is made and spliced, the nucleus was nearly devoid of 5.8S rRNA. We validated Y10b staining by treating sections with RNase A and micrococcal nuclease enzymes, which degrade RNA and thus the Y10b epitope. Compared with control, sections pretreated with nucleases had substantially less Y10b labeling ( Figure 7A ; Figures S5A and S5B) .
In an effort to detect ribosomes in CB 1 -expressing axon terminals, we performed 3D STORM imaging (Huang et al., 2008) . Using a recently developed combined STORM/confocal imaging approach that reliably measures CB 1 position in the plasma membrane (Barna et al., 2016; Dudok et al., 2015) , we visualized 5.8S rRNA molecules within CB 1 -expressing axon terminals (Figure 7B ) located in the somatic and dendritic fields of CA1 (Figure S5B) . Nuclease pretreatment largely eliminated 5.8S rRNA immunostaining from these terminals (Figures 7A and 7D ; Figure S5B ).
In a complementary set of experiments, we immunolabeled ribosomal protein S6 (rpS6), which is an integral component of the eukaryotic 40S ribosomal subunit and an effector of mTOR signaling. rpS6 molecules also were readily visualized with STORM imaging inside CB 1 -expressing axon terminals (Figure 7C ; Figure S5C ). The densities of 5.8S rRNA ( Figure 7D ) and rpS6 protein ( Figure 7E ) puncta were significantly higher (by $90%) in axon terminals compared to the corresponding background signal measured from CA1 pyramidal cell nuclei. Preterminal axon segments exhibited an intermediate labeling density. Quantitative nanoscale analysis showed an identical clustering distribution for 5.8S rRNA and rpS6 localization points within CB 1 -expressing axon terminals ( Figure 7F) , and dualchannel STORM revealed co-clustering of 5.8S rRNA and rpS6 molecules in these boutons (Figures S6A-S6C) . The mean number (±SD) of 5.8S rRNA and rpS6 clusters per bouton was 3.34 ± 0.79 and 2.92 ± 1.16, and the percentage of ribosomecontaining boutons was 91% ± 7% and 83% ± 18%, respectively. As expected, CB 1 -expressing axon terminals containing the presynaptic active zone protein bassoon also showed ribosomal labeling ( Figures S6D-S6G ). Presynaptic 5.8S rRNA STORM signal was observed in CB 1 -expressing axon terminals from rat hippocampal sections, and signal specificity was confirmed in nuclease-treated sections (control, n = 57 boutons versus nuclease treatment, n = 56 boutons, two animals each; p < 0.0001, Mann-Whitney U test; data not shown). Interestingly, presynaptic ribosomal labeling also was detected in parvalbumin-positive inhibitory interneuron boutons ( Figure S7 ). The number of 5.8S rRNA and rpS6 clusters per bouton was 2.41 ± 0.84 and 2.42 ± 1.03, and the percentage of ribosomecontaining boutons was 82% ± 11% and 77% ± 14%, respectively. Jointly, these data provide strong anatomical support for eukaryotic ribosomes in mammalian axon terminals of inhibitory interneurons.
To determine the nanodomain distribution of ribosomes within presynaptic CB 1 -expressing interneuron terminals, we employed dual-channel 3D directSTORM imaging. We previously established that CB 1 localization points, which delimit the Figure 7 . Ribosomes Are Present in CB 1 -Expressing Interneuron Axons and Terminals (A) Fixed mouse hippocampal slices were immunostained against 5.8S rRNA using the monoclonal Y10b antibody (green) and CB 1 antibody (blue). Deconvolved confocal image of 5.8S rRNA immunostaining in CA1 cell body layer reveals heavily labeled perinuclear cytoplasm of pyramidal cells (asterisks). Note the characteristically dense meshwork of axons and preterminal axon segments expressing CB 1 receptors (box). Compared with control, sections pretreated with nuclease enzymes had significantly less 5.8S rRNA immunolabeling (quantified in D), confirming the specificity of the antibody and labeling procedure. (B) Representative maximum intensity volume view of correlated confocal and 3D STORM microscopy images shows 5.8S rRNA immunolabeling inside a CB 1 -expressing axon terminal (A, white box). An area within CB 1 -expressing axon terminals was selected from the central confocal slice using an unbiased active contour algorithm (gold outline in xy plane of B and C). The number of STORM localization points within these ROIs was used to calculate density values for each bouton. (C) Similar to (B), but for ribosomal protein, rpS6. Same imaging modality as in (B) is shown. (D) Left panel: pretreatment with nuclease enzymes decreased STORM localization point density in CB 1 -expressing axon terminals (n = 28 ± 2 SDs, unpaired t test). Right panel: interneuron axon terminals (n = 29 ± 1) contained significantly more ribosomal labeling compared to preterminal axon segments (n = 13 ± 3) and pyramidal cell nuclei (n = 4), representing background staining, one-way ANOVA. Each graph shows raw data normalized to control axon terminals (n = 3 mice per condition). (E) Similarly, rpS6 immunopositive STORM-labeling density was significantly higher in axon terminals (n = 21 ± 3) than background staining in nuclei (n = 4); oneway ANOVA. Preterminal segments, n = 13 ± 2. (F) Nanoscale spatial distribution of 5.8S rRNA and rpS6 immunolabeling was virtually identical (cf. Figures S6A-S6C) . Maximal clustering between pairs of localization points occurred near $50 nm (note apparent clustering of points in B and C). ε refers to the Euclidian distance between point pairs that are confined by the active contour border. The y axis refers to the number of point pairs separated by <ε normalized to a randomized distribution of such point pairs for each distance. Filled symbols represent the mean and error bars the 95% confidence interval. (G) Dual-channel 3D STORM imaging of CB 1 and 5.8S rRNA immunolabeling shows high density of ribosomal material at the inner plasma membrane surface of CB 1 -expressing axon terminals (n = 25 boutons, two mice, representative images in H). The outer surface of the bouton was largely devoid of 5.8S rRNA immunolabeling. The signal was present at low density in surrounding neuropil and accumulated in neighboring cells with distance from the terminals. Filled symbols are mean ± 95% confidence interval. NLP, number of localization points. (H) Dual-channel 3D volume renderings of two adjacent CB 1 -expressing axon terminals (single arrowhead and double arrowhead) demonstrate 5.8S rRNA immunolabeling inside the convex hull fit to CB 1 localization points (silver lines). Dotted line indicates neighboring postsynaptic neuron cell body (asterisk). presynaptic bouton, can be fit with a convex hull with nanoscale precision (Dudok et al., 2015) , thereby defining the membrane of the axon terminal ( Figure 7H ). Dual-STORM imaging uncovered 5.8S rRNA within CB 1 -expressing axon terminals ( Figures 7G  and 7H) . Quantitative nanoscale distribution analysis uncovered a high density of 5.8S rRNA within the presynaptic terminal just inside the plasma membrane ( Figure 7G; Figures S6D-S6G ). The density of 5.8S rRNA just outside the presynaptic plasma membrane, corresponding to the synaptic cleft and interstitial space, was virtually zero ( Figure 7G ). Taken together, these findings provide molecular and anatomical evidence for the presence of presynaptic ribosomes inside CB 1 -expressing interneuron terminals.
DISCUSSION
We established that presynaptic protein synthesis is essential for a presynaptically expressed form of long-term plasticity in the mature mammalian brain. We found that CB 1 activation generates new proteins and that iLTD likely requires axonal protein synthesis independent of somatic translation, transcription, and microtubule-based trafficking mechanisms. Our combined molecular and anatomical approach revealed eukaryotic ribosomes in fully developed CB 1 -expressing interneuron axon terminals. Mechanistically, CB 1 activation drives the cap-dependent translation machinery via the mTOR pathway. Translation plays a specific role in long-term plasticity since disrupting translation initiation or peptide elongation did not affect basal GABA release or short-term plasticity. We also report that protein synthesis is required for the induction, but not maintenance, of iLTD. These findings converge on a novel model whereby presynaptically synthesized proteins act as a molecular switch to persistently reduce GABA release from inhibitory interneuron terminals.
Neurons must coordinate gene expression at thousands of synapses distant from their soma. Local translation can impart axons and dendrites with computational autonomy to rapidly respond to the environment, independent of the soma (Alvarez et al., 2000; Holt and Schuman, 2013; Jung et al., 2014) . The concept of local presynaptic protein synthesis was first proposed nearly 50 years ago (for a thorough review, see Alvarez et al., 2000) . Presynaptic local protein synthesis during longterm plasticity has since been demonstrated in non-mammalian preparations such as crayfish (Beaumont et al., 2001) , sea slug (Martin et al., 1997) , frog (Zhang and Poo, 2002) , and leech (Yuan and Burrell, 2013 ). An advantage of these preparations is that the presynaptic axons are relatively large and can be directly manipulated via pressure injection of translation inhibitors. In contrast, mammalian axons are much smaller and therefore more difficult to access. Previous research in rodents has so far relied on non-physiological treatments, such as axotomy or non-specific manipulations like blocking postsynaptic protein synthesis to infer a role for presynaptic translation during longterm plasticity (Barnes et al., 2010; Calixto et al., 2003; Hagena and Manahan-Vaughan, 2013; Huang and Hsu, 2004; Huang et al., 1994; Kelly et al., 2000; Yin et al., 2006) . Protein synthesis can be upregulated in response to injury or occur in neighboring neurons or glia. We used long-term paired recordings and single-cell manipulations in a locally intact circuit to demonstrate that presynaptic, likely axonal, protein synthesis is essential for regulating neurotransmitter release during long-term plasticity. Our findings also indicate that presynaptic protein synthesis during long term-plasticity is evolutionarily conserved from invertebrates to mammals.
The presence of ribosomes has been well documented in mammalian axonal growth cones, regenerating axons, and peripheral sensory axons (Crispino et al., 2014; Jung et al., 2014) , However, failure to detect ribosomes in mature mammalian CNS axons (Palay and Palade, 1955) and the observation that neuronal somata can source protein to axons (Droz and Leblond, 1963) likely gave rise to the notion that presynaptic compartments in the mature mammalian brain do not synthesize proteins. This dogma persisted despite ribosomes being identified in axon initial segments of mammalian cortical principal cells (Jones and Powell, 1969; Steward and Ribak, 1986) and spinal nerves . Ribosome-associated proteins and initiation and elongation factors have now been detected in whole-brain presynaptic bouton preparations (Wilhelm et al., 2014) , and hundreds of mRNA transcripts encoding presynaptic proteins were isolated from cultured cortical axons (Taylor et al., 2009) , hippocampal slices of CA1 neuropil (Cajigas et al., 2012) , and retinal ganglion cell axons in vivo (Shigeoka et al., 2016) . In addition, axonal protein synthesis recently has been linked with synaptic transmission and axon maintenance (Shigeoka et al., 2016; Yoon et al., 2012) , which may be dysregulated in Alzheimer's disease (Baleriola et al., 2014) and fragile X syndrome (Akins et al., 2012; Christie et al., 2009) . These studies and ours collectively raise the strong possibility that the soma is not the exclusive origin of presynaptic proteins. Further, our work establishes that presynaptic ribosomes play a functional role in presynaptic long-term plasticity.
Our findings using various protein synthesis inhibitors suggest that presynaptic CB 1 -expressing interneuron terminals contain eukaryotic ribosomes. We used super-resolution STORM microscopy to provide direct evidence for ribosomes in axonal boutons and to quantify, in a cell-type-and synapse-specific manner, their nanoscale spatial distribution. We found a high density of ribosomes within 25-400 nm of the presynaptic plasma membrane, where they are positioned to integrate CB 1 signaling. It is unclear why previous ultrastructural studies in mature CNS axons failed to detect ribosomes in synaptic terminals. Presumably, those studies lacked sufficient sensitivity to detect ribosomes or focused exclusively on excitatory synapses. Alternatively, ribosomes in certain presynaptic terminals may be disassembled, and, thus, they go undetected until an external cue (e.g., activity or receptor ligand) initiates translation (Tcherkezian et al., 2010) . It is also conceivable that certain presynaptic terminals express unconventional ribosomes (Xue and Barna, 2012) . Regardless of the underlying biological or technical explanation, our study demonstrates that eukaryotic ribosomes are present in fully mature CNS inhibitory interneuron terminals.
CB 1 can transduce signals to several downstream effectors including voltage-gated Ca 2+ and K + channels, PKA, ERK/ MAPK, p38-MAPK, and PI3K (Howlett et al., 2002) . Many of these signaling cascades were originally characterized in heterologous overexpression systems. Thus, the precise pathways engaged by CB 1 in intact preparations remain unclear. A previous study reported that CB 1 activation can indirectly upregulate mTOR signaling, presumably in postsynaptic compartments (Puighermanal et al., 2009) . Instead, we found that both synaptically and chemically induced iLTD are coupled to mTOR, suggesting that mTOR signaling operates in presynaptic compartments. Using FUNCAT in cultured hippocampal neurons, we also directly showed that CB 1 activation leads to new protein synthesis in an mTOR-dependent manner. To our knowledge, this is the first demonstration that CB 1 activation causes an overall increase in protein synthesis. Though it is presently not possible to distinguish between a requirement for constitutive and/or de novo protein synthesis during forms of plasticity in which target protein(s) remain unidentified, mTOR can control eIF4F-mediated cap-dependent translation initiation, a highly regulated and rate-limiting step (Sonenberg and Hinnebusch, 2009 ). Given our findings that eIF4F is critical for iLTD, these results imply that CB 1 activation enhances the rate of protein synthesis. Novel methods with improved spatiotemporal resolution need to be developed to reveal de novo protein synthesis at presynaptic terminals in brain tissue.
Protein synthesis is commonly linked to the maintenance of long-term plasticity (Buffington et al., 2014; Santini et al., 2014) . We found that blocking translation right after inducing iLTD had no effect on long-term plasticity. This observation is consistent with our previous work indicating CB 1 activation is required during the induction, but not maintenance, of iLTD (Chevaleyre and Castillo, 2003) . Given that CB 1 receptors enhance translation, the newly synthesized protein(s) may act as a functional molecular switch to inhibit neurotransmitter release and therefore trigger long-term, but not short-term, plasticity. Once the protein(s) are synthesized and iLTD is established, protein translation is no longer required to maintain the synapse in a depressed state (Klein et al., 2015) . While additional research is needed to identify exactly which protein(s) are synthesized, candidates include the translation machinery itself; synaptic vesicle-associated signaling proteins; and structural proteins linked with the cytoskeleton, active zone, and intercellular adhesion. There is evidence that actin can be locally synthesized in axon growth cones, sensory axons, and cultured CNS axons (for reviews, see Gomes et al., 2014 and Jung et al., 2014) and that CB 1 activation leads to cytoskeletal rearrangements, including axon growth cone collapse/ expansion (Argaw et al., 2011; Berghuis et al., 2007; Njoo et al., 2015; Roland et al., 2014) . Synthesis of a structural/cytoskeletal protein could increase the coupling distance between presynaptic calcium channels and the active zone to efficiently suppress GABA release.
The impact of iLTD manifests at the circuit level. CB 1 receptors expressed on the axon terminals of interneurons can persistently gate excitation via somatic and dendritic disinhibition (Basu et al., 2013; Younts et al., 2013) . In vivo studies suggest that redistribution of inhibitory interneuron spiking and spike timing can reconfigure ensembles of active hippocampal pyramidal cells in space and time (Dupret et al., 2013; Klausberger et al., 2005) . We propose that presynaptic translation in inhibitory interneurons helps orchestrate the excitability of a subset of pyramidal cells in specific circuits established during the learning processes. Given the important role of protein synthesis in cognitive functions (Buffington et al., 2014; Santini et al., 2014) , our results also warrant consideration in the context of dysregulated translational control and inappropriately balanced excitation and inhibition. Dysregulated translation in inhibitory interneurons may be an overlooked mechanism in brain disorders (Buffington et al., 2014; Darnell and Klann, 2013) .
EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures for detailed methods.
Slice Preparation and Electrophysiology
Acute transverse hippocampal slices (400 mm thick) were prepared from male and female (post-natal day [P]15-30) Sprague-Dawley rats and C57BL/6 mice using standard procedures approved by the NIH and Albert Einstein College of Medicine Institutional Animal Care and Use Committee. Whole-cell voltage and current clamp recordings were performed with an Axon MultiClamp 700B amplifier (signals filtered at 2 kHz and digitized at 5 kHz). Stimulation and acquisition were controlled with custom software (Igor). Stock reagents were prepared according to the manufacturer's recommendation. All experiments were performed in an interleaved fashion (n represents the number of independent cells or field recordings in slices).
FUNCAT and Image Analysis
Acute hippocampal slices (400 mm thick) or primary hippocampal neurons (from embryonic day [E]18-19 rats and grown in vitro for 18 days) were prepared using standard procedures. Slices were treated with reagents as described and then exposed to azidohomoalanine (AHA) for 2.5 hr before fixation. Neuron cultures were pre-incubated with methionine-free medium for 30 min, then incubated with AHA for 1.5 hr and treated with reagents, as described. Following the Click-it reaction, immunocytochemistry was performed. Images were obtained using the same settings for all samples within an experiment. The experimenter was blind to the treatment condition. Image processing was performed with ImageJ (NIH).
STORM Microscopy and Image Analysis
Experimental procedures were approved by the Hungarian Committee of the Scientific Ethics of Animal Research. Acute hippocampal slices (300 mm thick) were prepared from male Sprague-Dawley rats and C57BL/6N mice (P30-40) according to standard procedures. Tissue processing, immunostaining, and imaging were performed as described (Barna et al., 2016; Dudok et al., 2015) . After data acquisition, the confocal images were deconvolved. Identification of single-molecule localization points was performed with NIS-Elements N-STORM module (Nikon). Correlated analysis of confocal and STORM images was performed in VividSTORM. Localization precision was measured from the SD of coordinates in isolated clusters (Dudok et al., 2015) at 13 and 34 nm in the lateral and axial dimensions, respectively. The localization accuracy for determining the position of one blinking event was 6.8 nm with singlechannel STORM and 10.6 nm with dual-channel STORM. The 3D STORM renderings of localization points were constructed using Visual Molecular Dynamics software. All images within each experiment were processed in parallel using identical imaging and analysis conditions. Statistics Summary data are presented as mean ± SEM unless otherwise indicated. Significance (p < 0.05) was assessed with one-way ANOVA (means comparison with post hoc Bonferroni test for electrophysiology and FUNCAT or Tukey test for STORM), Student's paired and unpaired t tests, Wilcoxon matchedpairs signed-rank test, Mann-Whitney U test, or Pearson's correlation coefficient, as indicated. 
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